OTCMKTS:FSDDF FSD Pharma (FSDDF) Stock Price, News & Analysis → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free FSDDF Stock Alerts $0.46 -0.02 (-4.13%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$0.46▼$0.4950-Day Range$0.46▼$1.0652-Week Range$3.43▼$68.66Volume108,838 shsAverage Volume11,100 shsMarket Capitalization$3.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get FSD Pharma alerts: Email Address Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. About FSD PharmaFSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.Read More FSDDF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FSDDF Stock News HeadlinesNovember 27, 2023 | benzinga.comFSD Pharma Inc. Obtains Final Order for Plan of ArrangementMay 12, 2023 | msn.comFSD Pharma gets court complaint alleging breach of nondisclosure agreementApril 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...March 31, 2023 | morningstar.comFSD Pharma Inc Ordinary Shares - Class B (Sub Voting)March 23, 2023 | benzinga.comFSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive DisorderMay 10, 2022 | finance.yahoo.comFSD Pharma Closes CAD$16.4 Million Sale of Non-Core AssetsApril 21, 2022 | finance.yahoo.comLatest Version of Skyland PIMS® Advances IDBS' Mission to Accelerate BioPharma ManufacturingSee More Headlines Receive FSDDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Agricultural Commodities & Milling Sub-IndustryN/A Current SymbolOTCMKTS:FSDDF CUSIPN/A CIKN/A WebN/A Phone(416) 854-8884FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.81 Quick Ratio1.60 Sales & Book Value Annual Sales$70,000.00 Price / Sales50.26 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares7,580,000Free FloatN/AMarket Cap$3.52 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Anthony John Durkacz (Age 43)Founder & Co-Chairman Dr. Raza Bokhari M.B.A. (Age 51)MBA, Exec. Co-Chairman & Interim CEO Mr. Zeeshan SaeedFounder, Pres & DirectorMr. Donal CarrollInterim CFODr. Sara MayPres of FV PharmaKey CompetitorsTempest TherapeuticsNASDAQ:TPSTCorvus PharmaceuticalsNASDAQ:CRVSInstil BioNASDAQ:TILJourney MedicalNASDAQ:DERMMediciNovaNASDAQ:MNOVView All Competitors FSDDF Stock Analysis - Frequently Asked Questions How have FSDDF shares performed in 2024? FSD Pharma's stock was trading at $0.9198 on January 1st, 2024. Since then, FSDDF stock has decreased by 49.5% and is now trading at $0.4641. View the best growth stocks for 2024 here. How do I buy shares of FSD Pharma? Shares of FSDDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:FSDDF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
